2018-05-08T12:18:56-05:00 2017-10-31 BKD LLP 14241 DALLAS PARKWAY SUITE 1100 DALLAS TX 75254 990 2016-11-01 760442781 El Centro de Corazon % MARCELLE MIR ELCE 7136601880 PO Box 230209 Houston TX 77223 PAULINA PUTMAN CFO 7136601880 2018-07-15 true Jeanette Verrelli P00742631 9727028262 2016 2022-09-23 18:48:47Z MARCELLE MIR PO BOX 230209 HOUSTON TX 77223 11347032 false X N/A X 1994 TX TO PROMOTE THE INDIVIDUAL COMMUNITY AND SOCIAL HEALTH OF THE EAST END AND THE GREATER HOUSTON AREA BY PROVIDING PEDIATRIC, PRE-NATAL, PRIMARY CARE ... (SEE SCH O) 8 8 107 9 0 0 3965553 4274664 6558739 6974659 -5869 -788 38183 7822 10556606 11256357 41076 0 0 0 6678189 7174770 0 0 164733 3028304 3179303 9747569 10354073 809037 902284 6113128 7105647 669020 759255 5444108 6346392 X TO PROMOTE THE INDIVIDUAL COMMUNITY AND SOCIAL HEALTH OF THE EAST END & THE GREATER HOUSTON AREA BY PROVIDING PEDIATRIC, PRE-NATAL, PRIMARY CARE, AND OTHER HEALTH SERVICES TO THE COMMUNITY. false false 7937437 6982481 PEDIATRICS/FAMILY MEDICINE: HEALTH CARE IS OFFERED TO LOW INCOME, UNINSURED, AND UNDERINSURED CHILDREN AND FAMILIES. IN FISCAL YEAR 2017, EL CENTRO HAD 12,665 PEDIATRIC ENCOUNTERS AND 7,444 FAMILY MEDICINE ENCOUNTERS. DENTAL: DENTAL CARE IS OFFERED TO LOW INCOME, UNINSURED, AND UNDERINSURED CHILDREN. IN FISCAL YEAR 2017, EL CENTRO HAD 7,136 ENCOUNTERS. PRE-NATAL: EL CENTRO ALSO OFFERS PRE-NATAL CARE AND OTHER OBSTETRIC SERVICES. IN FISCAL YEAR 2017, EL CENTRO HAD 15,638 OB/GYN ENCOUNTERS. 7937437 true true false false false false false false false false true false false false false false true false false false false false false false true false false false false true false false false false false false false false false false false false false false false false false true 49 0 107 true false false false false false true true false false false false X 8 8 false false false false false false false true false false false true true true true true true true true false X MARCELLE MIR 7136601880 412 TELEPHONE ROAD HOUSTON TX 77023 X DOUG GRAHAM CHAIR 1.0 0.0 X X 0 0 0 JOEL SHANNON VICE CHAIR 1.0 0.0 X X 0 0 0 MELISSA FISHER TREASURER 1.0 0.0 X X 0 0 0 NIKE OTUYELU SECRETARY 1.0 0.0 X X 0 0 0 LUPE OLIVAREZ JR DIRECTOR 1.0 0.0 X 0 0 0 CAROL PARET DIRECTOR 1.0 0.0 X 0 0 0 MARIA PEREYRA-GONZALEZ DIRECTOR 1.0 0.0 X 0 0 0 PAMELA TYNER DIRECTOR 1.0 0.0 X 0 0 0 Richard Valdez Treasurer End: July 2017 1.0 0.0 X X 0 0 0 O Clayton Lilienstern Director End: July 2017 1.0 0.0 X 0 0 0 Reeve Van Nostrand Director End: July 2017 1.0 0.0 X 0 0 0 MARCELLE MIR CEO 40.0 0.0 X 139684 0 23856 PAULINA PUTMAN CFO 40.0 0.0 X 120656 0 18447 SHANNON HART DIRECTOR OF OPERATIONS 40.0 0.0 X 112780 0 6751 KAVON YOUNG MEDICAL DIRECTOR 40.0 0.0 X 202049 0 10982 SOUZAN SIDDIG MD PHYSICIAN 40.0 0.0 X 144449 0 19692 ANAYDA LANDRY MD PEDIATRICIAN 40.0 0.0 X 160051 0 12285 DANELIA CASTELLON MD PHYSICIAN 40.0 0.0 X 170289 0 12062 MOHAMMAD SARFRAZ MD PHYSICIAN 40.0 0.0 X 247217 0 31660 1297175 0 135735 8 false true false KNS 2601 CARTWRIGHT RD STE 144 MISSOURI CITY TX 77459 IT SERVICES 241900 UNITED SOLUTIONS MSO 3030 E 29TH STREET SUITE 101 BRYAN TX 77802 THIRD PARTY BILLING 255866 LABORATORY CORPORATION OF AMERICA PO BOC 12140 BURLINGTON NC 27216 LAB SERVICES 322487 3 X 63636 2791876 1419152 10806 4274664 Net Patient Service Revenue 624100 6974659 6974659 6974659 649 649 0 0 0 0 0 27165 28602 -1437 -1437 -1437 62073 63636 62073 0 0 0 0 0 0 0 0 Other revenue 900099 7822 7822 7822 11256357 6982481 -788 0 0 0 0 634897 493018 141879 0 5552469 4308736 1111572 132161 64283 48517 12455 3311 401536 318060 82650 826 521585 338251 174214 9120 0 558 558 78146 78146 0 0 0 1032685 924698 107987 17328 275 17053 618291 483770 133244 1277 0 0 410604 324525 86079 31714 31714 0 33758 16357 17181 220 250 250 0 228416 180449 47967 51125 34885 16240 Bad debt expense 112534 112534 Dues & subscriptions 97589 25920 70904 765 Repairs & Maintenance 56360 44482 11878 Provider Referrals 268537 268327 210 141408 14633 126775 10354073 7937437 2251903 164733 1641146 2530058 1017735 1010418 358505 158353 527154 774640 0 0 0 0 0 0 145403 125899 79775 106623 3876158 1476502 2343410 2399656 0 0 0 0 0 0 0 0 0 0 6113128 7105647 669020 759255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 669020 759255 X 5074985 5760281 369123 586111 0 0 5444108 6346392 6113128 7105647 902284 X false true X true true true X 3161184 3509339 3768853 3965553 4274664 18679593 0 0 3161184 3509339 3768853 3965553 4274664 18679593 377763 18301830 36 652 649 1337 0 0 0 0 0 0 0 18680930 29232669 0.97971 0.97300 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 356394 356394 2131955 710208 1421747 2250 2250 1075174 702497 372677 310385 61547 248838 2399656 11546822 612942 1028919 1641861 9904961 1351396 1351396 11256357 10917342 612942 62861 675803 10241539 112534 112534 10354073 SCHEDULE D, PART X, LINE 2 ASC 740 FOOTNOTE: MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. SCHEDULE D, PART XI, LINE 2D RECONCILIATION OF REVENUE PER AUDITED FINANCIALS WITH RETURN: NET ASSETS RELEASED FROM RESTRICTION $1,141,453 BAD DEBT EXPENSE (112,534) -------------- TOTAL $1,028,919 SCHEDULE D, PART XI, LINE 4B RECONCILIATION OF REVENUE PER AUDITED FINANCIALS WITH RETURN: TEMPORARILY RESTRICTED CONTRIBUTIONS $1,383,441 INTEREST INCOME 649 LOSS ON DISPOSAL OF ASSETS (1,437) FUNDRAISING EXPENSES (62,073) CONTRIBUTION FOR ACQUISITION OF PROPERTY & EQUIPMENT 30,816 -------------- TOTAL $1,351,396 SCHEDULE D, PART XII, LINE 2D RECONCILIATION OF EXPENSES PER AUDITED FINANCIALS WITH RETURN: INTEREST INCOME $ (649) LOSS ON DISPOSAL OF ASSETS 1,437 FUNDRAISING EXPENSES 62,073 --------- TOTAL $62,861 SCHEDULE D, PART XII, LINE 4B RECONCILIATION OF EXPENSES PER AUDITED FINANCIALS WITH RETURN: BAD DEBT EXPENSE $112,534 ANNUAL LUNCHEON 125709 63636 62073 2500 20903 13000 25670 0 125709 63636 62073 2500 20903 13000 25670 62073 X X false false false false false false false true false MARCELLE MIR CEO 134684 0 5000 0 0 0 4268 0 19588 0 163540 0 KAVON YOUNG MEDICAL DIRECTOR 199049 0 3000 0 0 0 4000 0 6982 0 213031 0 SOUZAN SIDDIG MD PHYSICIAN 142949 0 1500 0 0 0 0 0 19692 0 164141 0 ANAYDA LANDRY MD PEDIATRICIAN 158051 0 2000 0 0 0 4786 0 7499 0 172336 0 DANELIA CASTELLON MD PHYSICIAN 169789 0 500 0 0 0 4931 0 7131 0 182351 0 MOHAMMAD SARFRAZ MD PHYSICIAN 241217 0 6000 0 0 0 0 0 31660 0 278877 0 SCHEDULE J, PART I, LINE 7 NON-FIXED PAYMENTS: El Centro is competitive in the marketplace and awards all employees with annual discretionary bonuses based on each employees level of performance throughout the year. The discretionary bonus is dependent on the overall financial health of the organization on a year to year basis. FORM 990, PART VI, SECTION A, LINE 1A DELEGATION OF AUTHORITY: THE EXECUTIVE COMMITTEE CONSISTS OF THE BOARD CHAIR, VICE CHAIR, TREASURER AND SECRETARY. THE COMMITTEE HAS MONTHLY CALLS WITH THE CEO TO REVIEW THE NEEDS AND TRENDS OF THE ORGANIZATION BETWEEN BOARD MEETINGS. Form 990, Part VI, Section A, Line 8b Documentation of Commitee meetings: The Board of Directors and Finance Committee records and approves minutes as items are reviewed, discussed, and/or approved at each meeting. The Finance Committee approves items at each meeting and moves these items forward to the Board of Directors for final approval. The Executive Committee does not record and approve minutes since no items discussed/reviewed are approved at the Executive Committee that will be recommended for approval to the Board of Directors. FORM 990, PART VI, SECTION B, LINE 11B PROCESS TO REVIEW THE FORM 990: THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM BASED ON THE AUDITED FINANCIAL STATEMENTS AND INFORMATION PROVIDED BY THE ACCOUNTING DEPARTMENT OF THE ORGANIZATION. A DRAFT OF THE 990 WILL BE REVIEWED BY TOP MANAGEMENT AND THE FINANCE COMMITTEE PRIOR TO A FINAL DRAFT REVIEW BY THE FULL BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C PROCESS TO MONITOR COMPLIANCE WITH CONFLICT OF INTEREST POLICY: THE PURPOSE OF THE CONFLICT OF INTEREST POLICY IS TO PROTECT THE CORPORATION'S INTEREST WHEN IT IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF AN OFFICER OR DIRECTOR (INTERESTED PERSON) OF THE CORPORATION. PROCEDURE: IN CONNECTION WITH A PROPOSED TRANSACTION OR ARRANGEMENT, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS OR HER FINANCIAL INTEREST TO THE DIRECTORS AND MEMBERS OF THE BOARD OR, IF APPLICABLE, BOARD COMMITTEE CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DETERMINE IF A CONFLICT OF INTEREST EXISTS. IF A CONFLICT OF INTEREST IS DETERMINED TO EXIST, THE INTERESTED PERSON SHALL NOT VOTE ON THE PROPOSED TRANSACTION OR ARRANGEMENT, AND MAY NOT BE PRESENT WHEN THE PROPOSED TRANSACTION OR ARRANGEMENT IS DISCUSSED, UNLESS THE REMAINING BOARD MEMBERS REQUEST THE INTERESTED PERSON'S INPUT FOR INFORMATIONAL PURPOSES. AN INTERESTED PERSON HAS A FINANCIAL INTEREST IF THE INTERESTED PERSON HAS, DIRECTLY OR INDIRECTLY, THROUGH BUSINESS INVESTMENT OR FAMILY: (I) AN OWNERSHIP (OR POTENTIAL OWNERSHIP) INTEREST IN ANY ENTITY WITH WHICH THE CORPORATION HAS A TRANSACTION OR ARRANGEMENT, OR (II) A COMPENSATION ARRANGEMENT (OR POTENTIAL COMPENSATION ARRANGEMENT) WITH ANY ENTITY OR INDIVIDUAL WITH WHICH THE CORPORATION HAS A TRANSACTION OR ARRANGEMENT (OR POTENTIAL TRANSACTION OR ARRANGEMENT). ANNUAL STATEMENT SIGNED BY THE BOARD MEMBER: A STATEMENT ACKNOWLEDGING THAT YOU HAVE READ, UNDERSTAND, AND ACCEPT THE TERMS OF THE POLICY STATEMENT IS NECESSARY TO COMPLY WITH THE PROVISIONS OF THE BYLAWS AND MEET IRS REQUIREMENT. "I HEREBY ACKNOWLEDGE EL CENTRO DE CORAZON'S CONFLICT OF INTEREST POLICY AND AGREE TO FULLY DISCLOSE TO ABSTAIN FROM VOTING ON, AND/OR ABSTAIN FROM USING INFLUENCE ON ANY MATTER, IN WHICH I HAVE OR MAY HAVE A DUALITY OF INTEREST OR POSSIBLE CONFLICT OF INTEREST. I FURTHER AGREE TO REPORT TO EL CENTRO DE CORAZON ANY SITUATION THAT MIGHT BE CONSIDERED A DUALITY OF INTEREST OR POSSIBLE CONFLICT OF INTEREST, WHICH MAY OCCUR PRIOR TO THE COMPLETION OF MY NEXT STATEMENT OF DISCLOSURE OF CERTAIN INTERESTS." ALL STAFF MEMBERS, INCLUDING CORPORATE OFFICERS, ARE ALSO REQUIRED TO ANNUALLY CONSIDER POTENTIAL CONFLICTS OF INTERESTS. STAFF IS EXPECTED TO AVOID SITUATIONS WHERE THERE MAY APPEAR TO BE A CONFLICT BETWEEN WHAT IS IN HIS/HER BEST INTEREST AND THE BEST INTEREST OF EL CENTRO OR ITS PATIENTS. FORM 990, PART VI, SECTION B, LINE 15A CEO AND TOP MANAGEMENT OFFICIAL COMPENSATION REVIEW: THE BOARD OF DIRECTORS ANNUALLY REVIEWS THE CHIEF EXECUTIVE OFFICER'S COMPENSATION AND DETERMINES COMPENSATION USING THE ANNUAL TACHC SALARY AND BENEFIT REPORT. THE REVIEW IS DOCUMENTED IN THE HR ADMINISTRATOR'S FILES. FORM 990, PART VI, SECTION B, LINE 15B OTHER OFFICERS AND KEY EMPLOYEES COMPENSATION REVIEW: A REVIEW OCCURS ANNUALLY AT THE END OF EACH FISCAL YEAR. THE CEO EVALUATES OTHERS IN THE MANAGEMENT TEAM USING THE ANNUAL TACHC SALARY AND BENEFIT REPORT, AND THE MANAGEMENT TEAM AND DEPARTMENT HEAD MAKE COMPENSATION DECISIONS FOR THE REMAINING EMPLOYEES. THE LAST COMPENSATION REVIEW WAS PERFORMED IN MARCH 2017 BY MARCELLE MIR, CEO. THE REVIEW IS DOCUMENTED IN THE HR ADMINISTRATOR'S FILES. FORM 990, PART VI, SECTION C, LINE 19 AVAILABILITY OF DOCUMENTS: ORGANIZATION DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST FOR A LEGITIMATE BUSINESS PURPOSE, AS DETERMINED BY TOP MANAGEMENT, DEPENDING ON THE DOCUMENTS REQUESTED. THE ITEMS WILL EITHER BE EMAILED OR AVAILABLE FOR ON-SITE VIEWING. FORM 990, PART I, LINE 1 ORGANIZATION'S MISSION: (CONTINUED FROM PAGE 1)...AND OTHER HEALTH SERVICES TO THE COMMUNITY.